COVID-19 vaccination in Israel

From Wikipedia, the free encyclopedia

Date19 December 2020 (2020-12-19) – present
LocationIsrael
TargetFull immunisation of people in Israel against COVID-19
COVID-19 vaccination in Israel
Date19 December 2020 (2020-12-19) – present
LocationIsrael
CauseCOVID-19 pandemic in Israel
TargetFull immunisation of people in Israel against COVID-19
The President of Israel, Reuven Rivlin, with the first vaccinator in Phase B of the vaccine, at the Israel Institute for Biological Research, BriLife at the Barzilai Medical Center.

Israel's COVID-19 vaccination programme, officially named "Give a Shoulder" (Hebrew: לתת כתף),[1] began on 19 December 2020, and has been praised for its speed, having given twenty percent of the Israeli population the first dose of the vaccines' two dose regimen in the span of three weeks.[2][3][4]

As of June 26, 2021, about 64% of eligible Israelis have received at least one dose.[needs update] Coordinated vaccination drives by the country's health authorities, utilizing databases of personal information for Israeli patients, contributed to Israel's success in vaccinating a high proportion of its population in a short period of time, relative to the rest of the world.

According to a September 2021 study published in The Lancet, COVID-19 vaccination in Israel prevented an additional 158,665 infections, 24,597 hospitalisations, 17,432 severe or critical hospitalisations, and 5,532 deaths from December 20, 2020, to April 10, 2021.[5]

Vaccines on order

Many factors contributed to the quick distribution of vaccines in the state of Israel. Israel's population is younger on average than many other developed countries, with 12% of its population over the age of 65.[6][4] (→ Demographics of Israel)

Israel is smaller in land area than many other developed nations. It has a comparatively small population of about 9.3 million people and a high population density (424/km2). Israel's organized response in terms of attaining, storing and distributing vaccines was considered to be overall well coordinated. This is in part owed to the centralized nature of Israel's government system, which for example does not defer many health policy decisions to lower state-level bodies of government. The state purchased a substantial amount of Pfizer–BioNTech COVID-19 vaccines relative to its population as early as December 2020.[4][7] In May 2020, the state secured agreements with companies which were developing vaccines, such as Moderna.[8]

Vaccine Approval Deployment
Pfizer–BioNTech Yes Yes
Moderna Yes Yes

Vaccines in trial stage

Vaccine Type (technology) Phase I Phase II Phase III
Pfizer–BioNTech ZUBR HMAR Completed Completed Completed
The Israel Institute for Biological Research Viral vector Completed Completed N/a
MigVax-101 VLP Not yet Not yet Not yet

History

Distribution issues

References

Related Articles

Wikiwand AI